Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fletcher

Showing results (101-110 of 205) with videos related to

Pageof 21
Sort By:
Genes, Chromosomes & Cancer|May 13, 2004
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcomaIoannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D M Fletcher, et al.
British Journal of Cancer|November 29, 2019
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumoursMengyuan Huang, Wenyu Yang, Jiaqing Zhu, et al.
Current Protocols in Human Genetics|April 3, 2016
Reporting of Diagnostic Cytogenetic ResultsAnne B S Giersch, Frederick R Bieber, Adrian M Dubuc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other BiomarkersSuzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Oncogene|September 23, 2018
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanomaLillian R Klug, Amber E Bannon, Nathalie Javidi-Sharifi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2013
Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangementCheng-Han Lee, Lien N Hoang, Stephen Yip, et al.
Oncogene|August 3, 2019
Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independenceWen-Bin Ou, Nan Ni, Rui Zuo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindredFrederick P Li, Jonathan A Fletcher, Michael C Heinrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2018
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcomeMatthew L Hemming, Matthew A Lawlor, Rhamy Zeid, et al.
British Journal of Cancer|September 13, 2022
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcomaElisa Fiorito, Patrycja Szybowska, Ellen M Haugsten, et al.
Pageof 21

Showing results (101-110 of 205) with videos related to

Sort By:
Pageof 21
Genes, Chromosomes & Cancer|May 13, 2004
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcomaIoannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D M Fletcher, et al.
British Journal of Cancer|November 29, 2019
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumoursMengyuan Huang, Wenyu Yang, Jiaqing Zhu, et al.
Current Protocols in Human Genetics|April 3, 2016
Reporting of Diagnostic Cytogenetic ResultsAnne B S Giersch, Frederick R Bieber, Adrian M Dubuc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other BiomarkersSuzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Oncogene|September 23, 2018
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanomaLillian R Klug, Amber E Bannon, Nathalie Javidi-Sharifi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 2013
Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangementCheng-Han Lee, Lien N Hoang, Stephen Yip, et al.
Oncogene|August 3, 2019
Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independenceWen-Bin Ou, Nan Ni, Rui Zuo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindredFrederick P Li, Jonathan A Fletcher, Michael C Heinrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2018
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcomeMatthew L Hemming, Matthew A Lawlor, Rhamy Zeid, et al.
British Journal of Cancer|September 13, 2022
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcomaElisa Fiorito, Patrycja Szybowska, Ellen M Haugsten, et al.
Pageof 21